VERAPAMIL HYDROCHLORIDE- verapamil hydrochloride tablet, extended release

Țară: Statele Unite ale Americii

Limbă: engleză

Sursă: NLM (National Library of Medicine)

Cumpara asta acum

Ingredient activ:

VERAPAMIL HYDROCHLORIDE (UNII: V3888OEY5R) (VERAPAMIL - UNII:CJ0O37KU29)

Disponibil de la:

Northwind Pharmaceuticals

INN (nume internaţional):

VERAPAMIL HYDROCHLORIDE

Compoziție:

VERAPAMIL HYDROCHLORIDE 240 mg in 30

Calea de administrare:

oral

Tip de prescriptie medicala:

PRESCRIPTION DRUG

Statutul autorizaţiei:

Abbreviated New Drug Application

Caracteristicilor produsului

                                VERAPAMIL HYDROCHLORIDE- VERAPAMIL HYDROCHLORIDE TABLET, EXTENDED
RELEASE
NORTHWIND PHARMACEUTICALS
----------
NDC: 51655-956-52
MFG: 68462-260-05
Verapamil Hydrohloride ER 240 MG
30 tablets
RX only
Lot#: NW08220001
Exp. Date: 02/2016
Each extended release tablet film-coated tablet contains verapamil
hydrochloride USP 240mg.
Dosage: See package insert
Store at 68 to 77 degrees F. Protect from light and moisture.
Store in a tight, light-resistant container (See USP). Keep out of the
reach of children.
Mfg by: Glenmark Generics Ltd India for Glenmark Generics Inc, NJ USA
Lot# 02140734
Repackaged by: Northwind Pharmaceuticals, Indianapolis, IN 46256
VERAPAMIL HYDROCHLORIDE
verapamil hydrochloride tablet, extended release
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:516 55-9 56 (NDC:6 8 46 2-26 0 )
ROUTE OF ADMINISTRATION
o ra l
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
VERAPAMIL HYDRO CHLO RIDE (UNII: V38 8 8 OEY5R) (VERAPAMIL -
VERAPAMIL
240 mg
Northwind Pharmaceuticals
UNII:CJ0 O37KU29 )
HYDROCHLORIDE
in 30
PRODUCT CHARACTERISTICS
COLOR
bro wn
S CORE
no sco re
S HAP E
OVAL
S IZ E
19 mm
FLAVOR
IMPRINT CODE
G74
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:516 55-9 56 -52
30 in 1 BOTTLE, DISPENSING
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
ANDA
ANDA0 78 9 0 6
0 5/27/20 14
LABELER -
Northwind Pharmaceuticals (036986393)
REGISTRANT -
Northwind Pharmaceuticals (036986393)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
No rthwind Pharmaceuticals
0 36 9 8 6 39 3
re pa c k(516 55-9 56 )
Revised: 5/2014
                                
                                Citiți documentul complet
                                
                            

Căutați alerte legate de acest produs